Browsing Tag
London Stock Exchange
330 posts
Grafton Group (GFTU) closes Cygnum acquisition as Ireland’s timber frame construction push accelerates
Grafton Group (GFTU) completes Cygnum acquisition to expand in Ireland's timber frame housing sector. Discover what this means for investors and the industry. Read more.
Filtronic (AIM: FTC) wins new European defence prime contract, extending customer relationship into second business unit
Filtronic (AIM: FTC) wins European defence contract for wideband RF solution, breaking into a second prime business unit. Volume production expected. Read the full analysis.
Unilever to combine Foods business with McCormick in $44.8bn deal to create global flavour powerhouse
Unilever to sell its $44.8bn Foods business to McCormick in a Reverse Morris Trust deal. Read what this means for ULVR shareholders and MKC's leverage.
AVCT near 52-week high as Avacta doses first patient in AVA6103 Phase 1 trial
Avacta (AVCT) has treated the first patient in the FOCUS-01 Phase 1 trial of AVA6103, its Gen Two pre|CISION exatecan PDC. Initial data expected late 2026. Read more.
Seeing Machines (AIM: SEE) reports 33% royalty growth and 4.8 million cars on road as GSR countdown intensifies
Seeing Machines (AIM: SEE) reports 33% royalty growth and 4.8M cars on road in H1 FY2026 as EU GSR mandate approaches. Read our full analyis.
ImmuPharma (AIM: IMM) advances P140 patent and partnering push with new study data and peer-review manuscript in preparation
ImmuPharma's P140 clears UK patent examination as new study data and Bio-Europe partner meetings strengthen the 2026 licensing case. Read the full analysis.
Herald Investment Trust (LSE: HRI) board races to build cash war chest as Saba standoff stretches into spring
Herald Investment Trust (HRI) raises cash to 26% of NAV and explores tax-efficient rollover as the Saba Capital standoff enters a critical phase. Read the full analysis.
Avacta Group (AIM: AVCT) closes oversubscribed £10m placing at 9.35% discount as AVA6103 enters clinical dosing
Avacta Group (AIM: AVCT) completes an oversubscribed £10m equity placing at 63p ahead of late-2026 AVA6103 Phase 1 data. Read the full analyst breakdown.
NEXT plc (LON: NXT) delivers record profit of £1.16bn as international surge and brand portfolio drive 17% EPS growth
NEXT plc (LON: NXT) delivers record FY2026 pre-tax profit of £1,158m, 17% EPS growth, and 35% international sales surge. Full analysis of results, guidance and outlook. Read more.
Crest Nicholson (LSE: CRST) reports improving sales rate as Project Elevate repositioning gathers pace
Crest Nicholson (CRST) reports a 0.64 sales rate for the 10 weeks to 20 March as Project Elevate restructuring completes. Full analysis here. Read more.